Recombinant Vibrio vulnificus Uncharacterized protein YjeA (yjeA)

Shipped with Ice Packs
In Stock

Description

Definition and Overview

Recombinant Vibrio vulnificus Uncharacterized protein YjeA (yjeA) is a bioengineered version of the native YjeA protein produced through heterologous expression systems. The protein is derived from Vibrio vulnificus, a pathogenic bacterium known for causing severe infections in humans. While YjeA remains functionally uncharacterized in the literature, its recombinant form is commercially available for research purposes, typically produced in E. coli with engineered purification tags .

Expression Systems

Recombinant YjeA is primarily produced in E. coli due to its high yield and cost-effectiveness. Alternative systems (e.g., yeast, insect, or mammalian cells) may be employed to introduce post-translational modifications (PTMs) essential for structural or functional studies .

ParameterValue
Host OrganismE. coli (standard), yeast, insect/mammalian cells
Purification TagsN-terminal 10xHis tag, C-terminal Myc tag
Purity>85% (SDS-PAGE analysis)
Molecular WeightNot explicitly stated in sources

Sequence and Bioinformatics

The recombinant protein corresponds to the yjeA gene (Uniprot ID: Q8DCX0) from V. vulnificus strain CMCP6. The amino acid sequence includes motifs for membrane localization and substrate recruitment, though functional domains remain undefined .

Partial Sequence (N-terminal):
MQADWKPTAS IEQLRQRAVL IANIRQFFAQ RGVLEVDTPA MSHATVTDIH LHTFQTEFVG PGYAQGRHLH LMTSPEFHMK RLLAAGSGCI YQMAKAFRNE ENGRHHNPEF TMLEWYRVGF DHHQLMDEMD DLLQLILKCG

Functional Studies

As of 2025, no peer-reviewed studies have directly investigated YjeA’s biological role. Its classification as an "uncharacterized protein" reflects gaps in functional annotation. Potential roles inferred from homology to bacterial proteins include:

  • Membrane-associated processes: Sequence similarities suggest interactions with membrane-localized components .

  • Regulatory or chaperone functions: Structural motifs may imply involvement in protein folding or signal transduction.

Experimental Uses

Recombinant YjeA is used as a research tool for:

  1. Antibody production: For generating YjeA-specific antisera .

  2. Structural studies: Crystallization trials or NMR analysis (pending functional insights).

  3. Protein interaction assays: Exploring binding partners via pull-down or co-IP experiments.

Key Challenges

  • Functional ambiguity: No validated bioinformatics tools or experimental data link YjeA to specific pathways.

  • Limited strain representation: Commercially available YjeA originates from V. vulnificus CMCP6; strain-specific variations remain unexplored.

Research Priorities

  1. Functional genomics: Knockout mutant studies to assess phenotypic changes in V. vulnificus.

  2. Proteomic analysis: Mass spectrometry-based identification of interacting proteins.

  3. Structural biology: Determination of X-ray crystallography or cryo-EM structures to infer functional domains.

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
epmA; yjeA; VV3096Elongation factor P--(R)-beta-lysine ligase; EF-P--(R)-beta-lysine ligase; EC 6.3.1.-; EF-P post-translational modification enzyme A; EF-P-lysine lysyltransferase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-323
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Vibrio vulnificus (strain YJ016)
Target Names
epmA
Target Protein Sequence
MQADWKPTAS IEQLRQRAVL IANIRQFFAQ RGVLEVDTPA MSHATVTDIH LHTFQTEFVG PGYAQGRHLH LMTSPEFHMK RLLAAGSGCI YQMAKAFRNE ENGRHHNPEF TMLEWYRVGF DHHQLMDEMD DLLQLILKCG TAERMTYQQA FLTVLGVCPL EGSMAELKSV AARLGLSDIA EPEEDRDTLL QLLFSIGVEA KIGQQVPAFV YDFPASQAAL AKINPNDPRV ADRFEVYFKG IELANGFHEL DNPQEQLTRF EQDNAKRIDM GLTPQPIDYH LIAALESGLP ACAGVALGVD RLIMLSLGCT HIDEITAFPF PIA
Uniprot No.

Target Background

Function
EpmB participates in the β-lysylation step of the post-translational modification of translation elongation factor P (EF-P). It catalyzes the ATP-dependent activation of (R)-β-lysine (produced by EpmB), forming a lysyl-adenylate intermediate. The β-lysyl moiety is subsequently transferred to the ε-amino group of a conserved lysine residue within EF-P.
Database Links

KEGG: vvy:VV3096

Protein Families
Class-II aminoacyl-tRNA synthetase family, EpmA subfamily

Q&A

What is the genomic context of the yjeA gene in Vibrio vulnificus?

The yjeA gene in Vibrio vulnificus is located on the chromosome rather than on plasmids that often carry virulence-associated genes in this pathogen. Unlike the rtxA1 gene that encodes the MARTX toxin, which shows significant genetic variation across different isolates, the yjeA gene appears to be more conserved across biotypes . While not directly characterized in the available studies, analyses of Vibrio vulnificus genomic organization suggest that uncharacterized proteins like YjeA may be part of operons or genetic neighborhoods containing genes of related function. Researchers should examine flanking genes to identify potential functional relationships and regulatory elements that might control yjeA expression .

How can researchers determine if YjeA protein is expressed during human infection?

In vivo-induced antigen technology (IVIAT) represents an excellent methodological approach for determining whether proteins like YjeA are expressed during human infection. This technique identifies genes specifically expressed during human infections rather than laboratory conditions. The methodology involves:

  • Creating an expression library of V. vulnificus

  • Adsorbing convalescent-phase serum with in vitro-expressed V. vulnificus whole cells and lysates

  • Screening the expression library using the adsorbed serum

  • Analyzing reactive clones for antibody recognition

  • Sequencing and characterizing the identified genes

This approach has successfully identified several in vivo-expressed (ive) genes in V. vulnificus that contribute to virulence, including those encoding proteins involved in chemotaxis, signaling, metabolism, and transcriptional regulation . To determine if YjeA is expressed during infection, researchers should include it in such screening protocols to detect potential antibody recognition in convalescent serum.

What is currently known about the structural characteristics of YjeA protein?

While specific structural information about YjeA is not directly provided in the available studies, researchers approaching uncharacterized proteins in Vibrio vulnificus typically employ predictive bioinformatics tools to generate initial structural hypotheses. These include sequence homology modeling, secondary structure prediction, and identification of conserved domains.

For proteins like YjeA, researchers should investigate:

  • Presence of signal peptides indicating cellular localization

  • Transmembrane domains suggesting membrane association

  • Conserved motifs that might indicate enzymatic activity

  • Structural similarities to characterized proteins in related bacterial species

Computational approaches should be followed by experimental validation using techniques such as circular dichroism (CD) spectroscopy for secondary structure analysis, limited proteolysis for domain identification, and X-ray crystallography or cryo-electron microscopy for detailed structural characterization .

What methodological approaches are most effective for determining if YjeA contributes to Vibrio vulnificus virulence?

Determining the contribution of uncharacterized proteins like YjeA to virulence requires a multi-faceted approach that combines in vitro and in vivo methodologies:

  • Cytotoxicity assays: Measure lactate dehydrogenase (LDH) release from human cell lines (such as HeLa cells) exposed to wild-type and YjeA-deficient mutants.

  • Mouse infection models: Determine intraperitoneal 50% lethal dose (LD50) values for wild-type and mutant strains. Significant increases in LD50 (10-50 fold) would suggest virulence attenuation.

  • Intragastric infection models: Since V. vulnificus is primarily a food-borne pathogen, oral infection models can reveal the importance of YjeA in intestinal colonization and systemic spread.

  • Complementation studies: Reintroduce functional yjeA genes to confirm that observed phenotypes are directly attributable to the gene deletion.

These approaches have successfully identified key virulence factors in V. vulnificus, including PyrH, PurH, and HlyU, which when mutated showed dramatically reduced cytotoxicity and increased LD50 values in mice . Additionally, researchers should monitor bacterial growth in vivo to determine if YjeA is essential for survival in host environments or specifically contributes to virulence mechanisms.

How should researchers design experiments to investigate potential genetic recombination affecting the yjeA gene?

Given that V. vulnificus demonstrates significant genetic recombination in virulence-associated genes like rtxA1, researchers investigating potential recombination in yjeA should implement a comprehensive experimental design:

  • Sample collection: Obtain diverse V. vulnificus isolates representing:

    • Different biotypes (1, 2, and 3)

    • Various serovars within biotype 2

    • Clinical and environmental sources

    • Geographic and temporal diversity

  • PCR amplification and sequencing: Generate complete sequences of yjeA genes from all isolates.

  • Sequence analysis: Apply recombination detection algorithms and phylogenetic analysis to identify:

    • Mosaic structures indicative of recombination

    • Potential donor sequences from related species or plasmids

    • Recombination hotspots

  • Functional characterization: Compare activities of variant proteins to determine if recombination events alter function.

This approach could reveal whether yjeA undergoes genetic rearrangement similar to rtxA1, which has been shown to generate toxin variants with different arrangements of effector domains through recombination with plasmid-borne genes or genes from other Vibrio species like V. anguillarum .

Sample SourceNumber of StrainsYjeA Variant TypesRecombination Evidence
Biotype 1 (Clinical)30-40To be determinedTo be determined
Biotype 1 (Environmental)15-20To be determinedTo be determined
Biotype 2 (Serovar E)30-35To be determinedTo be determined
Biotype 2 (Other serovars)10-15To be determinedTo be determined
Biotype 35-10To be determinedTo be determined

What are the optimal conditions for expressing recombinant YjeA protein for structural studies?

Expressing recombinant Vibrio vulnificus YjeA protein requires careful optimization of expression systems and conditions. Researchers should consider:

  • Expression system selection:

    • E. coli BL21(DE3) for high-yield expression

    • Cell-free systems for potentially toxic proteins

    • Eukaryotic systems if post-translational modifications are suspected

  • Expression vector optimization:

    • Incorporate affinity tags (His6, GST, MBP) for purification

    • Include protease cleavage sites for tag removal

    • Consider codon optimization for heterologous expression

  • Induction and growth conditions:

    • Test multiple induction temperatures (16°C, 25°C, 37°C)

    • Evaluate different inducer concentrations (0.1-1.0 mM IPTG)

    • Optimize media composition and growth phase at induction

  • Solubility enhancement strategies:

    • Co-expression with chaperones (GroEL/GroES, DnaK)

    • Addition of solubility-enhancing fusion partners

    • Inclusion of specific additives in lysis buffers

  • Purification protocol development:

    • Multi-step chromatography (affinity, ion exchange, size exclusion)

    • Optimized buffer conditions to maintain stability

    • Quality control via SDS-PAGE, Western blotting, and mass spectrometry

Researchers should conduct small-scale expression trials before scaling up to optimize conditions for maximum yield of properly folded protein . Thermal shift assays can help identify stabilizing buffer conditions for purified YjeA protein.

How can researchers effectively identify potential interaction partners of YjeA in Vibrio vulnificus?

Identifying protein-protein interactions for uncharacterized proteins like YjeA requires systematic application of complementary techniques:

  • Pull-down assays: Express recombinant YjeA with affinity tags and identify binding partners from V. vulnificus lysates using mass spectrometry.

  • Bacterial two-hybrid systems: Test direct interactions with suspected partners based on genomic context or predicted function.

  • Co-immunoprecipitation: Generate antibodies against YjeA to pull down native protein complexes from V. vulnificus grown under various conditions.

  • Cross-linking mass spectrometry: Use chemical cross-linkers to stabilize transient interactions followed by mass spectrometry analysis.

  • Proximity-dependent biotin labeling: Express YjeA fused to enzymes like BirA or APEX2 to identify proteins in close proximity in vivo.

For interpreting results, researchers should prioritize interactions that are:

  • Reproducible across multiple techniques

  • Detected under infection-relevant conditions

  • Consistent with predicted subcellular localization

  • Functionally coherent with genomic context

This systematic approach has successfully identified interaction networks for virulence regulators like HlyU in V. vulnificus and could reveal whether YjeA participates in known virulence pathways or represents a novel virulence mechanism .

What experimental protocols should be employed to determine if YjeA expression varies between different Vibrio vulnificus biotypes and serovars?

To investigate potential variation in YjeA expression across V. vulnificus strains, researchers should implement a comprehensive analysis protocol:

  • Strain collection preparation:

    • Include representatives of all biotypes (1, 2, 3)

    • Cover multiple serovars within biotype 2 (E, A, O3, O3/O4)

    • Include both clinical and environmental isolates

  • Growth condition optimization:

    • Standard laboratory media (LB with 2% NaCl)

    • Iron-limited conditions (mimicking host environment)

    • Serum-supplemented media

    • In vivo-mimicking conditions

  • Expression analysis techniques:

    • Quantitative RT-PCR for transcriptional analysis

    • Western blotting for protein-level comparison

    • Promoter-reporter fusions to monitor regulation

  • Data analysis and interpretation:

    • Normalize expression to housekeeping genes

    • Compare expression patterns with virulence phenotypes

    • Correlate expression with biotype/serovar classification

The approach should be modeled after successful comparative studies that have examined gene distribution across V. vulnificus biotypes, such as those that identified biotype-specific and serovar-specific DNA sequences . Current evidence shows that some virulence-associated genes are differentially distributed among biotypes and serovars, with some sequences being specific to biotype 2 (plasmid-borne) or specifically to serovar E strains (chromosomal) .

Biotype/SerovarNumber of StrainsYjeA Expression LevelCorrelation with Virulence
Biotype 150+To be determinedTo be determined
Biotype 2, Serovar E30+To be determinedTo be determined
Biotype 2, Other serovars10+To be determinedTo be determined
Biotype 35+To be determinedTo be determined

How should conflicting data about YjeA function be reconciled in research publications?

When facing contradictory results regarding YjeA function, researchers should implement a systematic approach to data reconciliation:

  • Methodological comparison:

    • Evaluate differences in experimental systems (in vitro vs. in vivo)

    • Compare strain backgrounds used across studies

    • Assess technical variations in protocols

    • Consider statistical approaches and sample sizes

  • Conditional functionality assessment:

    • Test whether YjeA functions are condition-dependent

    • Evaluate effects of growth phase, temperature, salinity, and pH

    • Consider host factors that might influence protein activity

  • Strain-specific effects analysis:

    • Determine if contradictions arise from strain diversity

    • Compare clinical vs. environmental isolates

    • Assess biotype and serovar differences

  • Technical validation studies:

    • Replicate key experiments under standardized conditions

    • Use multiple complementary techniques to verify findings

    • Implement controls to rule out confounding factors

This systematic approach is particularly relevant for V. vulnificus research, as studies have shown unexpected variation in virulence gene function across strains. For example, research on the rtxA1 gene revealed that, contrary to expectations, the most common variant in clinical isolates encoded a toxin with reduced potency compared to variants from environmental strains . Such counterintuitive findings highlight the importance of thorough validation and contextual interpretation when studying uncharacterized proteins like YjeA.

What bioinformatic approaches are most valuable for predicting YjeA function based on sequence data?

To predict the function of uncharacterized proteins like YjeA, researchers should employ a comprehensive bioinformatic workflow:

  • Sequence homology analysis:

    • BLASTp searches against general and specialized databases

    • Position-Specific Iterated BLAST (PSI-BLAST) for distant homologs

    • Hidden Markov Model (HMM) searches using tools like HMMER

  • Structural prediction:

    • Secondary structure prediction (PSIPRED, JPred)

    • Tertiary structure modeling (AlphaFold2, I-TASSER)

    • Analysis of predicted binding pockets and active sites

  • Functional domain identification:

    • Conserved Domain Database (CDD) searches

    • InterProScan for functional classification

    • Motif identification using MEME and related tools

  • Genomic context analysis:

    • Operon structure prediction

    • Gene neighborhood conservation across Vibrio species

    • Identification of co-evolved gene clusters

  • Phylogenetic profiling:

    • Correlation of YjeA presence with specific phenotypes

    • Co-occurrence patterns with known virulence factors

    • Evolutionary rate analysis for selection pressure inference

This multi-faceted approach can generate testable hypotheses about YjeA function by leveraging information from various sources, similar to approaches used to identify the functions of novel virulence genes in V. vulnificus discovered through IVIAT . Researchers should prioritize experimental validation of predicted functions, particularly those suggesting roles in virulence or host adaptation.

How can researchers distinguish between direct and indirect effects when analyzing YjeA knockout phenotypes?

Distinguishing direct from indirect effects in YjeA functional studies requires careful experimental design and controls:

  • Complementation analysis:

    • Reintroduce wild-type yjeA gene to verify phenotype restoration

    • Use point mutants affecting specific domains to map functional regions

    • Implement tightly controlled expression systems to prevent artifacts

  • Temporal analysis of effects:

    • Monitor time-course of phenotypic changes after gene deletion

    • Use inducible knockout systems to observe immediate effects

    • Compare acute versus long-term adaptation to gene loss

  • Molecular pathway reconstruction:

    • Perform transcriptomic analysis of wild-type vs. knockout strains

    • Conduct metabolomic profiling to identify biochemical alterations

    • Use phosphoproteomic approaches to detect signaling changes

  • Genetic interaction mapping:

    • Generate double mutants with genes in suspected pathways

    • Look for synthetic phenotypes or epistatic relationships

    • Identify suppressors of yjeA deletion phenotypes

This systematic approach is comparable to methods used to characterize other V. vulnificus virulence genes like pyrH, purH, and hlyU, where isogenic mutants showed dramatic effects on cytotoxicity and virulence . The most informative experiments combine phenotypic characterization with molecular analysis to establish mechanistic links between gene function and observed phenotypes.

How might research on YjeA contribute to understanding Vibrio vulnificus biotype differentiation?

Research on YjeA may provide valuable insights into the genetic basis of V. vulnificus biotype differentiation, which has significant implications for understanding pathogenicity:

  • Comparative genomic analysis:

    • Determine if yjeA sequence variants correlate with biotype classification

    • Analyze if yjeA is part of biotype-specific genomic islands

    • Assess evolutionary history of yjeA across the Vibrio genus

  • Functional characterization across biotypes:

    • Compare YjeA activity in biotype 1 (human pathogenic) vs. biotype 2 (eel virulent) strains

    • Assess if YjeA contributes to host specificity

    • Evaluate biotype-specific regulation of yjeA expression

  • Potential applications:

    • Development of biotype-specific diagnostic markers

    • Identification of targets for biotype-specific interventions

    • Improved understanding of evolution toward different host ranges

Current research demonstrates that V. vulnificus biotypes contain distinct genetic markers, with biotype 2 strains sharing plasmid-borne sequences not found in other biotypes, and serovar E strains containing unique chromosomal sequences . Understanding whether yjeA shows similar patterns or contributes to these distinctions could provide valuable insights into the evolution of host specificity and virulence in this pathogen.

BiotypeHost RangeCharacteristic Genetic ElementsPotential YjeA Role
Biotype 1Primarily humanDiverse genotypesTo be determined
Biotype 2Primarily eelsShared plasmid-borne sequencesTo be determined
Biotype 3HumanHybrid genotypeTo be determined

What are the most promising approaches for using YjeA structure-function insights to develop novel antimicrobial strategies?

Translating YjeA research into antimicrobial applications requires a structured drug discovery pathway:

  • Target validation:

    • Confirm essentiality or critical virulence contribution

    • Demonstrate conservation across clinical isolates

    • Verify absence of functional homologs in humans

  • Structure-based drug design:

    • Obtain high-resolution structure through X-ray crystallography or cryo-EM

    • Identify druggable pockets through computational analysis

    • Perform virtual screening of compound libraries

  • Fragment-based approaches:

    • Screen fragment libraries using NMR or thermal shift assays

    • Identify binding fragments with potential for optimization

    • Link or grow fragments to improve potency and specificity

  • Peptidomimetic inhibitor development:

    • Identify interaction partners and interface residues

    • Design peptides that mimic critical interaction surfaces

    • Optimize for stability, cell penetration, and target engagement

  • Validation in infection models:

    • Test candidate inhibitors in cell-based infection assays

    • Evaluate efficacy in animal models of V. vulnificus infection

    • Assess potential for resistance development

This approach mirrors successful antimicrobial development strategies targeting virulence factors in other pathogens and could be applicable to YjeA if it proves to be a critical factor in V. vulnificus pathogenesis . Given the high mortality rate associated with V. vulnificus infections and increasing antibiotic resistance concerns, novel therapeutic approaches targeting specific virulence factors represent a promising research direction.

How can researchers effectively integrate YjeA studies with broader investigations of Vibrio vulnificus virulence mechanisms?

Integrating YjeA research into the broader context of V. vulnificus pathogenesis requires a systems biology approach:

  • Regulatory network mapping:

    • Determine if YjeA is regulated by known virulence regulators (ToxRS, HlyU)

    • Identify conditions that co-regulate yjeA with established virulence factors

    • Map potential roles in signaling cascades affecting multiple virulence mechanisms

  • Multi-omics integration:

    • Combine transcriptomic, proteomic, and metabolomic data

    • Position YjeA within global molecular networks

    • Identify functional modules where YjeA participates

  • Host-pathogen interaction studies:

    • Evaluate YjeA's role during different stages of infection

    • Assess contributions to specific virulence phenotypes (adhesion, invasion, cytotoxicity)

    • Determine if YjeA interacts with host factors

  • Collaborative research frameworks:

    • Establish standardized strains and methodologies across laboratories

    • Create shared databases of virulence factor characterization

    • Implement consistent infection models for comparable results

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.